Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Ainnocence Technologies LLC currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This active matter represents the current focus of the company's patent prosecution. The examination of this portfolio is conducted by 1 distinct examiner and is situated within 1 distinct art unit, reflecting a focused technical scope for the pending application.
The examiner assigned to this case is LUO, JAMMY NMN, who is listed as the busiest examiner with 1 pending office action. Because the 1 pending office action is the only one currently active, LUO, JAMMY NMN is responsible for the company's pending review. This concentration means the prosecution outcome is directly tied to the interactions with this specific examiner.
For the practitioner, working within 1 distinct art unit allows for a specialized focus on the relevant biotechnology standards. However, the lack of other pending matters means there are no alternative examiners to provide different perspectives on the portfolio. Success depends on navigating the specific requirements and feedback provided by LUO, JAMMY NMN within the 1 distinct art unit.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LUO, JAMMY NMN | 1 | — | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17811091 | SYSTEM AND METHOD OF ANTIBODY/ MACROMOLECULE DRUG AFFINITY MODIFICATION | LUO, JAMMY NMN | — |
| Art Unit | Apps |
|---|---|
| 1686 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17811091 | SYSTEM AND METHOD OF ANTIBODY/ MACROMOLECULE DRUG AFFINITY MODIFICATION | LUO, JAMMY NMN | 1686 | §101§103 | Final Rejection | — | Pending | Jul 07, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAinnocence Technologies LLC has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Jammy Nmn Luo has the most, with 1 of Ainnocence Technologies LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
